Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010
class="xn-location">Japan, Diagnosis Population, 2009-2016 42
Table 53: Gastrointestinal Disorder Therapeutics Market, Japan, Prescription Population, 2009-2016 43
Table 54: Gastrointestinal Disorder Therapeutics Market, Japan, Prescription Population, 2001-2009 43
Table 55: Gastrointestinal Disorder Therapeutics Market, Japan, Usage Patterns, 2001-2009 44
Table 56: Gastrointestinal Disorder Therapeutics Market, Japan, Usage Patterns, 2009-2016 45
Table 57: Irritable Bowel Syndrome Therapeutics Market, Global, Revenue ($m), 2001-2009 47
Table 58: Irritable Bowel Syndrome Therapeutics Market, Global, Revenue ($m), 2009-2016 47
Table 59: Irritable Bowel Syndrome Therapeutics Market, Global, Annual Cost of Treatment, 2001-2009 48
Table 60: Irritable Bowel Syndrome Therapeutics Market, Global, Annual Cost of Treatment, 2009-2016 48
Table 61: Irritable Bowel Syndrome Therapeutics Market, Global, Diseased Population, 2001-2009 49
Table 62: Irritable Bowel Syndrome Therapeutics Market, Global, Diseased Population, 2009-2016 49
Table 63: Irritable Bowel Syndrome Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 50
Table 64: Irritable Bowel Syndrome Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 50
Table 65: Irritable Bowel Syndrome Therapeutics Market, Global, Diagnosis Population, 2001-2009 51
'/>"/>
| SOURCE MarketsandMarkets Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
(Date:5/17/2013)... 2013 - Elsevier, a world-leading provider of scientific, technical ... publication of a recent study in Reproductive ... showing that those with an abnormal chromosomal composition can ... developed to blastocysts, thereby classifying the risk of genetic ... same group has undertaken a retrospective study, using their ...
(Date:5/17/2013)... 17, 2013 • First of its kind ... sustainability , New facility will help solve crop ... Syngenta unveiled its new crop research facility ... RTP Innovation Center. The first of its kind, $72 ... any agricultural climate and precisely measure plant inputs – ...
(Date:5/17/2013)... 17, 2013 Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2... good workers to Procter & Gambles manufacturing plant in Green ... and technology used by those workers is another matter. , ... Bounty and Puffs have increased 50 percent, with no machine ... companys Green Bay plant. The last time anybody built a ...
... Wis. -- The Congenital Heart Institute at ... are now utilizing VERICIS Cardiovascular Information System. VERCIS, developed ... images and is designed to improve patient care. , ... hospitals echocardiography labs, giving physicians network access to cardio ...
... Wisconsins biotechnology sector and other well-established biotech regions is ... News featuring Wisconsins biotech sector as Americas Third ... , ,The East and West Coasts are often regarded ... flourish, some believe Wisconsin is catching up. According to ...
Cached Biology Technology:To attract investment, convince manufacturers that regulatory reform is real 2To attract investment, convince manufacturers that regulatory reform is real 3Wisconsin's biotech industry recognized by national publication 2(Date:5/18/2013)... Orlando, FL (May 18, 2013) An increasing ... that require interventions to resolve, according to research ... In one study targeting obesity, researchers at the ... have a unique pattern of exhaled breath compared ... in volatile organic compound levels that can be ...
(Date:5/17/2013)... interaction of a group of proteins in the brain ... a new target that could increase cell survival. , ... of Biochemistry and published in the EMBO journal ... lead to new therapies for stroke and other brain ... the team which identified a protein, known as SUMO, ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2... -Philadelphia, Pa Two internationally recognized scientists with strong Philadelphia ... The award ceremony will be held at 5:30 p.m. on ... College of Physicians of Philadelphia, located at 19 South 22nd ... a Scottish chemist and philanthropist who had a love of ...
... craters they leave behind , F. Pacheco-Vazquez and J.C. ... It,s generally accepted that craters in the moons and ... some craters completely flat while others show central peaks? ... material appear to provide a solution to the long-standing ...
... informatics professionals, honors four leaders in biomedical and ... during AMIA,s Annual Symposium, Oct. 22-26, an event ... Washington Hilton over the coming week. The Signature ... the health sector have had significant, positive impact. ...
Cached Biology News:Philadelphia scientists to be honored with the John Scott Award 2Philadelphia scientists to be honored with the John Scott Award 3Crater shapes explained, how carnivorous plants bite, and doubts about faster-than-light neutrinos 2AMIA honors informatics professionals who are improving health, changing the world 2AMIA honors informatics professionals who are improving health, changing the world 3Rabbit polyclonal to SMURF 2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide (10-30 aa in length) at the N-term of first 50 aa of human SMURF 2. Entrez G...
... spontaneous ligand immobilization can be coupled with a ... receptor to create an affinity matrix of choice. ... via primary amines. Affi-Gel 10 gel couples neutral ... 11; Affi-Gel 15 gel couples acidic proteins with ...
Monocarboxylate (lactate) transporter 2...
MagSi monodispers, magnetic silica particles with modified surface for SO3 coupling chemistry....
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |